Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/15374416.2020.1860066 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Part 2 explores the transformative potential of artificial intelligence (AI) in addressing the complexities of headache disorders through innovative approaches, including digital twin models, wearable healthcare technologies and biosensors, and AI-driven drug discovery. Digital twins, as dynamic digital representations of patients, offer opportunities for personalized headache management by integrating diverse datasets such as neuroimaging, multiomics, and wearable sensor data to advance headache research, optimize treatment, and enable virtual trials. In addition, AI-driven wearable devices equipped with next-generation biosensors combined with multi-agent chatbots could enable real-time physiological and biochemical monitoring, diagnosing, facilitating early headache attack forecasting and prevention, disease tracking, and personalized interventions.
View Article and Find Full Text PDF20 International Congress on Infectious Diseases 2024 - Ubuntu in recognition of our interconnectedness, a call to community, solidarity, and humanity for all.
Int J Infect Dis
December 2024
International Society for Infectious Diseases; Department of Microbiology, Auckland City Hospital, Te Whatu Ora, Health New Zealand.
The Nuances of Performance Measurement and Clinical Guidelines.
Ann Intern Med
December 2024
University of Connecticut Health, Farmington, Connecticut (R.A.A.).
'Pharmacogenetics, health and ethnicity in Latin American populations' call for the "Dr José María Cantú Award 2024".
Drug Metab Pers Ther
January 2025
Red Iberoamericana de Farmacogenética y Farmacogenómica (RIBEF), Badajoz, Spain.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!